Enzo Biochem (ENZ) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts ENZ Hot Sheet
Price: $1.07 +0.94%
Financial Fact:
Loss before income taxes: -1.45M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Loss before income taxes: -1.45M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Enzo Biochem (NYSE: ENZ) reported Q2 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $24.6 million versus the consensus estimate of $24.43 million.
For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Allison Transmission (ALSN) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY24 Revenue Guidance
- SPS Commerce (SPSC) Tops Q1 EPS by 12c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
